New York State Common Retirement Fund
BHVN

New York State Common Retirement Fund’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

New York State Common Retirement Fund’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45,063
Closed -$6.81M – 3300
2022
Q3 		$6.81M Sell
45,063
-1,733
-4% -$257K 0.01% 1019
2022
Q2 		$6.82M Sell
46,796
-22,430
-32% -$2.87M 0.01% 1047
2022
Q1 		$8.21M Buy
69,226
+3,466
+5% +$432K 0.01% 1060
2021
Q4 		$9.06M Buy
65,760
+711
+1% +$90.4K 0.01% 1048
2021
Q3 		$9.04M Buy
65,049
+7,144
+12% +$892K 0.01% 1044
2021
Q2 		$5.62M Buy
57,905
+3,298
+6% +$268K 0.01% 1286
2021
Q1 		$3.73M Sell
54,607
-1,280
-2% -$104K ﹤0.01% 1419
2020
Q4 		$4.79M Sell
55,887
-1,300
-2% -$110K 0.01% 1275
2020
Q3 		$3.72M Buy
57,187
+1,400
+3% +$91.8K ﹤0.01% 1286
2020
Q2 		$4.08M Buy
55,787
+8,200
+17% +$436K 0.01% 1241
2020
Q1 		$1.62M Buy
47,587
+3,385
+8% +$155K ﹤0.01% 1510
2019
Q4 		$2.41M Sell
44,202
-3,700
-8% -$183K ﹤0.01% 1551
2019
Q3 		$2M Buy
47,902
+4,600
+11% +$194K ﹤0.01% 1644
2019
Q2 		$1.9M Buy
43,302
+7,086
+20% +$399K ﹤0.01% 1677
2019
Q1 		$1.86M Buy
36,216
+2,100
+6% +$90.7K ﹤0.01% 1657
2018
Q4 		$1.26M Sell
34,116
-2,297
-6% -$82.8K ﹤0.01% 1779
2018
Q3 		$1.37M Hold
36,413
– – ﹤0.01% 1912
2018
Q2 		$1.44M Sell
36,413
-2,735
-7% -$86.8K ﹤0.01% 1891
2018
Q1 		$1.01M Buy
39,148
+28,448
+266% +$851K ﹤0.01% 2022
2017
Q4 		$289K Sell
10,700
-8,294
-44% -$228K ﹤0.01% 2602
2017
Q3 		$710K Hold
18,994
– – ﹤0.01% 2189
2017
Q2 		$475K Buy
+18,994
New +$437K ﹤0.01% 2432

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

New York State Common Retirement Fund's BHVN Position: Q4 2022 in Review

New York State Common Retirement Fund sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 45,063 shares — an estimated $6.81M sold.

New York State Common Retirement Fund first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $9.06M in Q4 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • New York State Common Retirement Fund reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 45,063 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $6.81M.
  • New York State Common Retirement Fund first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • New York State Common Retirement Fund's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $9.06M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on New York State Common Retirement Fund's 13F filing for Q4 2022, filed 30 Jan 2023.